Home - Products - Others - Other Targets - N-(4-fluorophenyl)benzo[d]thiazol-2-amine

N-(4-fluorophenyl)benzo[d]thiazol-2-amine

CAS No. 348-45-8

N-(4-fluorophenyl)benzo[d]thiazol-2-amine( —— )

Catalog No. M28897 CAS No. 348-45-8

N-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 107 Get Quote
10MG 177 Get Quote
25MG 374 Get Quote
50MG 531 Get Quote
100MG 770 Get Quote
500MG 1521 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    N-(4-fluorophenyl)benzo[d]thiazol-2-amine
  • Note
    Research use only, not for human use.
  • Brief Description
    N-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
  • Description
    N-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CYP17
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    348-45-8
  • Formula Weight
    244.29
  • Molecular Formula
    C13H9FN2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (511.69 mM)
  • SMILES
    Fc1ccc(Nc2nc3ccccc3s2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang M, et al. Discovery of novel 1,2,3,4-tetrahydrobenzo[4, 5]thieno[2, 3-c]pyridine derivatives as potent and selective CYP17 inhibitors. Eur J Med Chem. 2017 May 26;132:157-172.
molnova catalog
related products
  • Endixaprine

    Endixaprine (SR 41378) is a small molecule compound used to treat neurological disorders and may be used to study anxiety disorders and epilepsy.

  • 1111-Kestohexose

    1111-Kestohexose is a natural product isolated from Poa ampla.

  • Clesrovimab

    Clesrovimab (MK1654) is an anti-respiratory syncytial virus protein F human monoclonal antibody for the prevention and treatment of respiratory syncytial virus infections.